EMR

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 4.62 B4.17 B4.43 B4.55 B4.86 B4.35 B 18.19 B Gross profit 2.37 B2.23 B2.37 B2.39 B2.52 B2.31 B 9.6 B Operating expenses 2.91 B1.25 B1.45 B1.33 B2.67 B1.25 B 6.7 B Selling/general/admin expenses 1.31 B1.22 B1.28 B1.27 B1.33 B1.24 B 5.12 B Research & development —————— — Operating income -542 M987 M923 M1.06 B-152 M1.06 B 2.9 B Non-Operating Income, Total -27 M94 M46 M39 M35 M64 M 184 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -2 M68 M29 M25 M11 M40 M 105 M Unusual income/expense -25 M26 M17 M14 M24 M24 M 79 M Pretax income 679 M775 M629 M734 M796 M775 M 2.93 B Equity in earnings —————— — Taxes 149 M182 M199 M154 M161 M169 M 683 M Non-controlling/minority interest -28 M8 M-55 M001 M -54 M After tax other income/expense —————— — Net income before discontinued operations 558 M585 M485 M580 M635 M605 M 2.31 B Discontinued operations 438 M006 M2 M— — Net income 996 M585 M485 M586 M637 M605 M 2.31 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 996 M585 M485 M586 M637 M605 M 2.31 B Basic earnings per share (Basic EPS) 1.741.030.861.041.131.08 4.11 Diluted earnings per share (Diluted EPS) 1.731.020.861.041.121.07 4.09 Average basic shares outstanding 571.3 M568.5 M563 M562.1 M564 M561.8 M 2.25 B Diluted shares outstanding 574 M571.1 M565.4 M564.7 M566.7 M564.1 M 2.26 B EBITDA -116 M1.37 B1.31 B1.44 B226 M1.42 B 4.39 B EBIT -542 M987 M923 M1.06 B-153 M1.06 B 2.89 B Cost of revenue 2.25 B1.94 B2.06 B2.16 B2.34 B2.04 B 8.59 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 426 M383 M384 M372 M379 M359 M 1.49 B